Test an AI score to guide liver transplant decisions
Part of Cancer, Digestive system clinical trials.
This study looks at a prediction tool that estimates outcomes for people with liver cancer and cirrhosis, to help decide whether a liver transplant is a good option. It may help doctors choose the right timing and patients who could benefit most from transplantation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have liver cancer (hepatocellular carcinoma) along with cirrhosis
- You are between 18 and 70 years old
- Your total tumor size is under 500 cubic centimeters (cm³)
- You have fewer than 10 tumor spots (lesions)
- Your largest single tumor is under 10 centimeters across
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses an AI tool to predict how liver cancer might come back after surgery. It is for people with early-stage liver cancer who are already scheduled for surgery and have recent MRI scans.
This study looks at whether different scoring tools can better predict outcomes for people with cirrhosis who are waiting for a liver transplant. It may help improve how transplant urgency is decided.
This study looks back at medical records of people who had liver cancer (HCC) and had either a transplant or surgery to remove the tumor. It aims to improve a tool that helps predict how well a patient may do, which could guide future treatment decisions.
This study uses artificial intelligence to look at your liver cancer's environment and predict how well it might respond to a combination treatment called TACE (which blocks blood flow to the tumor) plus immunotherapy and targeted therapy. It aims to help personalize your care by better understanding your tumor.
This study uses artificial intelligence on your CT scan to help doctors make better decisions before and after liver surgery. It aims to improve safety and outcomes for people having surgery for liver cancer or other liver conditions.
This trial uses artificial intelligence to help doctors better stage (classify the severity of) and plan treatment for hepatocellular carcinoma, a type of primary liver cancer. Researchers will collect your clinical information and imaging to see if AI can improve decision-making about your care.
Hear when a new Recurrence Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.